The effects of ACE2 expression mediating pharmacotherapy in COVID-19  patients

CONCLUSION: Analysis of the literature demonstrated that there was insufficient evidence to answer our objective on the effect of ACE2 expression mediating pharmacotherapy on outcome in COVID-19 patients, especially due to the low scientific quality of the described studies. Randomised controlled studies are needed to answer this question.PMID:33860910 | PMC:PMC8050813 | DOI:10.1007/s12471-021-01573-8

Source: Netherlands Heart Journal - April 16, 2021 Category: Cardiology Authors: R R J van Kimmenade E Belfroid J Hoogervorst-Schilp H J Siebelink C W Janssen Y Pinto Source Type: research